Deadline for manuscript submissions: 30 January 2022Print Special Issue Flyer (8)
PhD, academic researcher, Department of Medicine and Surgery, Division of Urology, University of Perugia, Italy
Interests: robotic surgery, uro-oncology, laser surgery, urologic functional disease, translational research
I am honored to be the guest editor of the official journal of the International Society of Men's Health.
Bladder cancer is a common malignant tumour worldwilde, specifically in males, with high morbidity and mortality. Approximately 25% of bladder cancer are muscle invasive and in these cases, as well as in some types of high malignant non muscle invasive bladder cancer, the gold standard therapy is the radical cystectomy which is characterized by high morbidity. The application of robotic approach to this type of surgery is increasingly widespread in order to improve perioperative and functional outcomes. Although several publications on robotic-assisted radical cystectomy have become available, many questions are still open and debated in Literature, thus which is the best surgical approach for radical cystectomy is still not established.
I would like to focus in this special issue the tips and tricks of this new technique, real advantages and disadvantages of robotic application, the comparison between open and robotic radical cystectomy as well as between intracorporeal and extracorporeal urinary diversion, in order to contribute to improve the knowledge about robot assisted radical cystectomy for urologic community.
This special issue offers an opportunity to address the following but other topics:
- Pre-operative management of patients undergoing robotic radical cystectomy
- New techniques of robotic radical cystectomy and intracorporeal urinary diversion
- Peri-operative, oncologic and functional outcomes of robotic radical cystectomy
- Post-operative management of patients undergone robotic radical cystectomy
- The role of neoadjuvant chemotherapy in patients undergoing robotic radical cystectomy
- New indications for robotic radical cystectomy
- Quality of life of patients undergone robotic radical cystectomy
Your contribution is welcome in form of original article, case report, commentary and review.
Dr. Dott. Giovanni Cochetti
bladder cancer, robot assisted radical cystectomy, urinary diversion, perioperative outcomes, oncologic outcomes, functional outcomes
Submissions will be accepted on a rolling basis and reviewed by experts in the field. Rapid peer review and prompt editorial decisions will ensure that quality manuscripts are published on time. The manuscript has not already been published or submitted elsewhere (except conference proceedings papers). If similar work has been published or submitted elsewhere, you must provide a copy of the submitted manuscript. You may not submit your manuscript elsewhere while it is under consideration at the Journal of Men's Health. All manuscripts undergo thorough double-blind peer-review. To check the suitability of the special issue for publishing your manuscript, please read the journal's aims and scope and read or download the guide for authors. You may also send a brief abstract of your work (about 100 words) to the Editorial Office at email@example.com. A guide for authors and other relevant information for manuscript submission is available on the Instructions for Authors page.
Academic Writing and English Language Editing Services
Authors who feel that their manuscript may benefit from additional academic writing or language editing support before submission are strongly encouraged to use academic editing services.
Article Processing Charges (APC)
All manuscripts submitted to the Journal of Men's Health are assessed according to the journal standard editorial criteria. If accepted for publication, an Article Processing Charge of 1250 USD applies.
Type of Articles: Original Research, Review, Mini-Review, Systematic Review, Short Communication, Case Report, Letter to the Editor, Commentary, Rapid Report, Meeting Report, News and Views
Science Citation Index Expanded Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Social Sciences Citation Index Social Sciences Citation Index contains over 3,400 journals across 58 social sciences disciplines, as well as selected items from 3,500 of the world’s leading scientific and technical journals. More than 9.37 million records and 122 million cited references date back from 1900 to present.
Current Contents - Social & Behavioral Sciences Current Contents - Social & Behavioral Sciences provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in the social and behavioral sciences.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
SCOPUS Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
DOAJ DOAJ is a community-curated online directory that indexes and provides access to high quality, open access, peer-reviewed journals.
CrossRef Crossref makes research outputs easy to find, cite, link, assess, and reuse. Crossref committed to open scholarly infrastructure and collaboration, this is now announcing a very deliberate path.
Portico Portico is a community-supported preservation archive that safeguards access to e-journals, e-books, and digital collections. Our unique, trusted process ensures that the content we preserve will remain accessible and usable for researchers, scholars, and students in the future.